Things that add significance to this outcome:
- This asset adaptable to many other forms of cancer apart from kidney (TLX250cdx) so expansion of asset pipeline huge
- GE partnership to push this asset (70 US billion $ company)
- break through designation and competitive edges that are attached to this designation
so much more
The world needs Telix
Ann: ZIRCON Ph III Imaging Study - Positive Top-Line Results, page-12
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.07 |
Change
0.030(0.20%) |
Mkt cap ! $4.979B | |||
| Open | High | Low | Value | Volume |
| $15.08 | $15.35 | $15.05 | $7.131M | 471.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 461 | $15.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.08 | 1660 | 1 |
View Market Depth
| Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$15.07 |
Change
0.030 ( 0.59 %) |
||||
| Open | High | Low | Volume | ||
| $15.24 | $15.34 | $15.06 | 60419 | ||
| Last updated 15.59pm 15/05/2024 ? | |||||
| TLX (ASX) Chart |